DEKKERS MARIJN E 5
5 · Cerevel Therapeutics Holdings, Inc. · Filed Feb 14, 2023
Insider Transaction Report
Form 5
DEKKERS MARIJN E
Director
Transactions
- Gift
Common Stock
2022-12-21−14,270→ 28,540 total
Holdings
- 602,326(indirect: See footnote)
Common Stock
Footnotes (1)
- [F1]Shares held directly and indirectly by Novalis LifeSciences Investments I, L.P., or Novalis LifeSciences. Marijn Dekkers, the Manager of the general partner of Novalis LifeSciences, has sole voting and dispositive power over the shares held by Novalis LifeSciences and, as a result, may be deemed to share beneficial ownership of the shares held by Novalis LifeSciences.